Blood flow in human tumors during hyperthermia therapy: Demonstration of vasoregulation and an applicable physiological model

A quantitative assessment of the effect of localized magnetic‐loop hyperthermia on blood flow was performed in 12 human tumors using the 133Xe clearance method. Because blood flow in these tumors changed in response to needle injection, a physiologically based, one‐compartment model was developed that included both a hyperemic and a steady‐state component. In six tumors, changes in blood flow induced by heat were also observed. The ability of tumor vessels to respond dynamically to stress and the degree of response may be predictive of tumor heating capacity and subsequent therapeutic response.

[1]  P. Vaupel,et al.  Effect of hyperthermia on tumor blood flow. , 1984, Biorheology.

[2]  F. K. Storm,et al.  Hyperthermia: Electromagnetic Heating of Deep-Seated Tumors , 1982, IEEE Transactions on Biomedical Engineering.

[3]  D. Morton,et al.  Clinical radiofrequency hyperthermia by magnetic-loop induction. , 1981, The Journal of microwave power.

[4]  B. Emami,et al.  Physiological effects of hyperthermia: response of capillary blood flow and structure to local tumor heating. , 1980, Radiology.

[5]  H. A. Eddy,et al.  Alterations in tumor microvasculature during hyperthermia. , 1980, Radiology.

[6]  P Vaupel,et al.  Effects of hyperthermia on normal and tumor microenvironment. , 1980, Radiology.

[7]  O. Henriksen,et al.  Evaluation of a method for determination of mean transit time of xenon-133 in the lungs. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  C. Song,et al.  Role of vascular function in response of tumors in vivo to hyperthermia. , 1980, Cancer research.

[9]  F. Stewart,et al.  Fractionation studies with combined X rays and hyperthermia in vivo. , 1980, The British journal of radiology.

[10]  K M Sekins,et al.  Muscle blood flow changes in response to 915 MHz diathermy with surface cooling as measured by Xe133 clearance. , 1980, Archives of physical medicine and rehabilitation.

[11]  M. Daly,et al.  Quantitative measurement of skin perfusion with xenon-133. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  M J Mäntylä,et al.  Regional blood flow in human tumors. , 1979, Cancer research.

[13]  J. Denekamp,et al.  The response of six mouse tumours to combined heat and X rays: implications for therapy. , 1979, The British journal of radiology.

[14]  J. Kim,et al.  Combination hyperthermia and radiation therapy for cutaneous malignant melanoma , 1978, Cancer.

[15]  H. Zarem,et al.  Computerized determination of blood flow in pedicle flaps by the clearance of epicutaneously applied 133xenon. , 1976, The Journal of surgical research.

[16]  Song Cw,et al.  Vascularity and blood flow in x-irradiated Walker carcinoma 256 of rats. , 1972 .

[17]  Y. Tanaka.  [Regional tumor blood flow and radiosensitivity]. , 1972, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

[18]  P. Sejrsen,et al.  Washout of 133Xenon after intramuscular injection and direct measurement of blood flow in skeletal muscle. , 1970, Scandinavian journal of clinical and laboratory investigation.

[19]  F. Gump,et al.  Determination of regional tumor blood flow by krypton‐85 , 1968, Cancer.

[20]  H. Barcroft,et al.  Validity of the 133Xenon Method for Determination of Muscle Blood Flow in Man as Evaluated by Simultaneous Venous Occlusion Plethysmography during Intravenous Infusions of Adrenaline , 1967 .

[21]  R. E. Peterson,et al.  Solubility of krypton and xenon in blood, protein solutions, and tissue homogenates. , 1965, Journal of applied physiology.